|
|
skeletal system development
|
GO:0001501 |
356 |
0.289
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.189
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.159
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.133
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.123
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.122
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.121
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.115
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.110
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.106
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.106
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.105
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.103
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.102
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.101
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.098
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.095
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.095
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.094
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.091
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.088
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.087
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.085
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.084
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.083
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.083
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.082
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.078
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.077
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.077
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.076
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.075
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.075
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.074
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.074
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.074
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.073
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.073
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.072
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.072
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.071
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.071
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.070
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.070
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.069
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.069
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.068
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.066
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.066
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.065
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.065
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.065
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.064
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.063
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.062
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.062
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.061
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.061
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.061
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.058
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.058
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.058
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.057
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.057
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.057
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.056
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.056
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.056
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.056
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.055
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.054
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.054
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.054
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.054
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.053
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.053
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.053
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.053
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.053
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.052
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.052
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.052
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.051
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.051
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.051
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.049
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.049
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.049
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.048
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.048
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.048
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.048
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.048
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.048
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.047
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.047
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.047
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.047
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.047
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.046
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.046
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.046
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.046
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.046
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.046
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.046
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.045
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.045
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.044
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.044
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.044
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.044
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.043
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.043
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.043
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.043
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.042
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.042
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.042
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.042
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.041
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.041
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.040
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.040
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.040
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.040
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.040
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.040
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.039
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.039
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.039
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.038
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.038
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.038
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.038
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.038
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.037
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.037
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.037
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.037
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.037
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.037
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.037
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.036
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.036
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.036
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.036
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.036
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.036
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.036
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.036
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.035
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.035
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.035
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.035
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.035
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.035
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.035
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.034
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.034
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.034
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.034
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.034
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.034
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.034
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.033
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.033
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.033
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.033
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.033
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.033
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.033
|
|
|
|
cell fate determination
|
GO:0001709 |
32 |
0.033
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.032
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.032
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.032
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.032
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.032
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.032
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.032
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.031
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.031
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.031
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.031
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.031
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.031
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.031
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.031
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.031
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.031
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.031
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.031
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.030
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.030
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.030
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.030
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.030
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.030
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.030
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.030
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.030
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.030
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.029
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.029
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.029
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.029
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.029
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.029
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.029
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.029
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.029
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.029
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.029
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.029
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.029
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.028
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.028
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.028
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.028
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.028
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.028
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.028
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.028
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.028
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.028
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.028
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.028
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.028
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.028
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.028
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.027
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.027
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.027
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.027
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.027
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.026
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.026
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.026
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.026
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.026
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.026
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.026
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.026
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.026
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.026
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.026
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.026
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.026
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.026
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.026
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.026
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.026
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.025
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.025
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.025
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.025
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.025
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.025
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.025
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.025
|
|
|
|
cellular glucose homeostasis
|
GO:0001678 |
52 |
0.025
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.025
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.025
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.025
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.024
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.024
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.024
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.024
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.024
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.024
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.024
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.024
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.024
|
|
|
|
tendon formation
|
GO:0035992 |
4 |
0.024
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.024
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.024
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.024
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.024
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.024
|
|
|
|
intracellular distribution of mitochondria
|
GO:0048312 |
1 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.024
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.024
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.024
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.024
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.023
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.023
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.023
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.023
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.023
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.023
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.023
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.023
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.023
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.023
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.023
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.023
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.023
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.022
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.022
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.022
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.022
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.022
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.022
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.022
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.022
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.022
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.022
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.022
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.022
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.022
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.022
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.022
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.021
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.021
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.021
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.021
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.021
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.021
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.021
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.021
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.021
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.021
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.021
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.021
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.021
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.021
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.021
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.021
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.021
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.021
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.021
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.021
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.020
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.020
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.020
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.020
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.020
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.020
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.020
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.020
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.020
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.020
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.020
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.020
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.020
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.020
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.020
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.020
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.020
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.020
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.019
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.019
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.019
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.019
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.019
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.019
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.019
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.019
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.019
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.019
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
cellular response to carbohydrate stimulus
|
GO:0071322 |
50 |
0.019
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.019
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.018
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.018
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.018
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.018
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.018
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.018
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.018
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.018
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.018
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.018
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.018
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.018
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.018
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.018
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.018
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.018
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.018
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.018
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.018
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.018
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.018
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.018
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.018
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.018
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.018
|
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.018
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.018
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.018
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.018
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.018
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.017
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.017
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.017
|
|
|
|
proprioception
|
GO:0019230 |
4 |
0.017
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.017
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.017
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.017
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.017
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.017
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.017
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.017
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.017
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.017
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.017
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.017
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.017
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.017
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.017
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.017
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.017
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.017
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.017
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.017
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.017
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.017
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.017
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.017
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.017
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.017
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.017
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.016
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.016
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.016
|
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.016
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.016
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.016
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.016
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.016
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.016
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.016
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.016
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.016
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.016
|
|
